TempraMed Signs Exclusive Distribution Agreement with SPORTORO for Croatia, Serbia and Bosnia and Herzegovina
Three-country commercial framework value of approximately US$550,000 over its initial three-year term based on VIVI Cap pricing at the scheduled...
Rosemont Pharmaceuticals to Acquire Aytu BioPharma in All-Cash Tender Offer